Page 87 - Sohini Das

Adar Poonawalla urges US Prez to lift ban on export of vaccine raw material

Poonawalla had said earlier that US curbs were hampering scale-up of Novavax vaccine at Pune. Serum has collaborated with Novavax of US to make its vaccine here and supply to Covax at $3 a shot

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

Behind India's ventilator crisis: Lack of trained staff and idle units

Oxygen makers flag concern over shortage of liquid oxygen

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The second wave: Covid-19 testing labs look at ways to ramp up capacity

Now demand is growing almost 100 per cent week-on-week, leading to a testing crisis, said an industry insider.

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature

Second Covid-19 wave: Hospitals running out of beds, staff overstretched

A year later, non-Covid treatments fall off priority list again

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose

Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July

Colour-coded doses will have two different antigens

Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine

Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India

Second Covid-19 wave: Govt releases vaccines; not enough, says Maharashtra

One of the largest government-run vaccination sites in Mumbai on the Bandra Kurla Complex grounds has only 350 vaccine doses left

Remdesivir output to be ramped up as Covid-19 cases rise sharply

Zydus had recently also slashed prices of its remdesivir brand Remdac to Rs 899 per dose

Second Covid wave: Fatalities threaten to be worse this time, shows data

Deaths due to Covid-19 usually happen two to three weeks after the diagnosis of the disease, according to research and doctors' accounts

AstraZeneca has sent us legal notice for vaccine supply delay: Poonawalla

For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla